Company news

Ceribell, Inc. (NASDAQ:CBLL) news

Every Ceribell, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Ceribell, Inc. stock analysis →

Press releases & updates

Ceribell Reports Second Quarter 2026 Financial Results

August 10, 2026

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

August 3, 2026

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

July 29, 2026

Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 28, 2026

Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026

July 20, 2026

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Ne...

June 8, 2026

Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference

May 20, 2026

Ceribell Reports First Quarter 2026 Financial Results

May 11, 2026

Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference

April 29, 2026

Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026

April 20, 2026

Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026

Ceribell to Participate in Upcoming March Investor Conferences

February 18, 2026

Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 10, 2026

Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution

January 5, 2026

Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 30, 2025

Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

December 9, 2025

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

November 24, 2025

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 19, 2025

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

November 6, 2025

Ceribell Reports Third Quarter 2025 Financial Results

November 4, 2025

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

October 21, 2025

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

September 22, 2025

Ceribell Reports Second Quarter 2025 Financial Results

August 5, 2025

Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 29, 2025

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

July 22, 2025

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

July 7, 2025

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

May 20, 2025

Ceribell Reports First Quarter 2025 Financial Results

May 8, 2025

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

April 30, 2025

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

April 30, 2025

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

April 24, 2025

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detecti...

April 15, 2025

Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results

February 25, 2025

Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference

February 18, 2025

Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing

November 19, 2024

Ceribell Reports Third Quarter 2024 Financial Results

November 12, 2024

Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs

November 11, 2024

CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional ...

October 15, 2024